Telehealth licensure requirements, DEA controlled substance prescribing rules, I-STOP registration requirements, and compliance checklist for physicians practicing telehealth in New York. Verified May 2026.
| Telehealth-specific license | ✓ Not required — standard license |
| IMLC compact pathway | — No — direct application required |
| Informed consent | — Required before telehealth |
| Audio-only permitted | ✓ Permitted |
| Medicaid parity | ✓ Yes — parity in effect |
| Out-of-state registration | ✓ Not required |
| Renewal fee | $600 |
| Telehealth prescribing | ✓ Permitted |
| Prior in-person visit | — Required (Ryan Haight) |
| DEA special registration | ✓ Not required |
| Schedule II (stimulants, opioids) | ✓ Permitted |
| Buprenorphine (MAT) | ✓ Permitted |
| Stimulants (ADHD) | ✓ Permitted |
| Benzodiazepines | ✓ Permitted |
| Program name | I-STOP |
| Registration required | Required before prescribing |
| Required for schedules | Schedule II–IV |
No — New York does not require a separate telehealth-specific license. A standard New York medical license covers telehealth practice.
No — New York is not currently an IMLC compact member. Physicians must apply directly through the New York medical board.
Yes — telehealth prescribing is permitted in New York. A prior in-person visit is required under the Ryan Haight Act. COVID-era DEA telehealth prescribing extension in effect; permanent rule pending
Yes — New York requires physicians to register with the I-STOP before prescribing Schedule II–IV controlled substances. Must query I-STOP before prescribing Schedule II–IV. Mandatory for all controlled substance prescriptions.
Yes — New York permits audio-only (phone) telehealth encounters without video.
Add New York to your tracked states. Set renewal reminders. Get email alerts when telehealth rules or DEA prescribing requirements change. 14-day free trial, no credit card.
StateLicensure is a regulatory research platform — not a legal service. Data is sourced from official state boards, DEA, and CMS, and updated as rules change. For compliance decisions with regulatory consequences, confirm requirements directly with your state board.
